Duchenne Muscular Dystrophy Global Market Report 2023
Major players in the duchenne muscular dystrophy market are Bristol Myers Squibb Company, FibroGen Inc., Italfarmaco SpA, NS Pharma Inc., Pfizer Inc., PTC...
Source: globenewswire.com
Page 16 - Solid Biosciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Solid Biosciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Solid Biosciences Today - Breaking & Trending Today
Ultragenyx's manufacturing facility, Massachusetts, USA
Ultragenyx Pharmaceutical opened its first large-scale gene therapy manufacturing facility in Bedford, Massachusetts, in June 2023.
Source: pharmaceutical-technology.com
Curing the incurable: FDA makes history, approves Elevidys to treat pediatric Duchenne muscular dystrophy
The U.S. Food and Drug Administration approved Elevidys in June, making it the first gene therapy designed to treat pediatric Duchenne muscular dystrophy, a life-threatening genetic disorder of progressive muscular weakness.
Source: dailynexus.com
Cell And Gene Therapies Face Manufacturing Capacity Constraints
The increasing numbers of cell and gene therapy pipeline candidates, along with a steady growth of new approvals, are stretching manufacturing capacity to its limits.
Source: forbes.com